{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:06:55Z","timestamp":1788174415902,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to analyze temporal trends in the age- and sex-specific burdens of varicella zoster virus (VZV), including incidence, prevalence, mortality, and disability-adjusted life years (DALYs) in China from 1990 to 2021, and to predict the burden of varicella zoster in China for 2030 by comparing the trends with the global burden of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from the Global Burden of Disease database (1990\u20132021) were used to analyze the characteristics of varicella zoster virus (VZV) burden in China and globally, including trends in incidence, prevalence, mortality, and disability-adjusted life years (DALYs). The average annual percentage change (AAPC) and its corresponding 95% confidence interval (95% CI) were calculated using Joinpoint to assess the VZV burden trends. A comprehensive comparative analysis of the differences in VZV burden between China and the global population was conducted across multiple dimensions, including age, gender, and time period. Additionally, an autoregressive integrated moving average (ARIMA) model was used to predict the VZV trend from 2021 to 2030.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 1990 and 2021, the age-standardized incidence rate (ASIR) of varicella zoster in China decreased from 1,274.93\/100,000 to 1,270.58\/100,000, while the global ASIR increased from 1,244.05\/100,000 to 1,248.59\/100,000. In China, the age-standardized prevalence rate (ASPR) decreased slightly from 72.27\/100,000 to 72.03\/100,000, whereas the global ASPR rose from 66.67\/100,000 to 67.16\/100,000. The age-standardized disability-adjusted life year rate (ASDR) in China decreased significantly, from 17.68\/100,000 to 4.66\/100,000, while the global ASDR decreased from 19.28\/100,000 to 12.31\/100,000. Similarly, China\u2019s age-standardized mortality rate (ASMR) declined significantly, from 0.40\/100,000 to 0.05\/100,000, while the global ASMR decreased from 0.35\/100,000 to 0.19\/100,000. Over the same period, the average annual percentage change (AAPC) of ASIR, ASPR, ASMR, and ASDR in China was \u22120.0056, \u22120.0131%, \u22126.84%, and \u22124.24%, respectively, while the global AAPC for these metrics was 0.0119, 0.0183, \u22121.97%, and \u22121.42%, respectively. Additionally, age and gender had a significant impact on the burden of varicella zoster. The trends in ASIR and ASPR were notably influenced by age, while ASMR and ASDR exhibited a significant increasing trend with age. Projections indicate that the ASDR of varicella zoster in China will continue to decrease by 2030, while the ASIR, ASPR, and ASMR are expected to remain stable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Between 1990 and 2021, the incidence, prevalence, mortality, and DALYs of VZV in China demonstrated a declining trend, reflecting a relative reduction in the VZV burden. Women are more susceptible to VZV infection and face a higher risk of mortality than men. In contrast, the global disease burden remains higher than that in China. Projections suggest a slight decrease in the VZV burden in China by 2030. However, due to the country\u2019s large and aging population, VZV will continue to pose a significant public health challenge.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1535977","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:47:40Z","timestamp":1741589260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of trend analysis of varicella zoster disease burden between China and the world 1990\u20132021 and disease burden forecast 2030"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhichun","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huale","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingren","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"25151355221084535","DOI":"10.1177\/25151355221084535","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review","volume":"10","author":"Pan","year":"2022","journal-title":"Therap Adv Vaccines Immunother"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1002\/jmv.27538","article-title":"The global disease burden of varicella-zoster virus infection from 1990 to 2019","volume":"94","author":"Huang","year":"2022","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12889-025-21348-9","article-title":"Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017-2022): a registry-based case-cohort study","volume":"25","author":"Xiong","year":"2025","journal-title":"BMC Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1016\/j.vaccine.2023.11.015","article-title":"Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia","volume":"41","author":"Shrestha","year":"2023","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12889-024-21273-3","article-title":"Three in four children age 12-23 months missed opportunities for vaccination in sub-Saharan African countries: a multilevel mixed effect analysis of demographic health and surveys 2016-2023","volume":"25","author":"Jejaw","year":"2025","journal-title":"BMC Public Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jiph.2023.05.016","article-title":"The necessity for popularizing varicella-zoster virus vaccine programs worldwide: an age-period-cohort analysis for the global burden of disease study 2019","volume":"16","author":"Zhang","year":"2023","journal-title":"J Infect Public Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","article-title":"A systematic literature review of herpes zoster incidence worldwide","volume":"17","author":"van Oorschot","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2228169","DOI":"10.1080\/21645515.2023.2228169","article-title":"The incidence of herpes zoster in China: a meta-analysis and evidence quality assessment","volume":"19","author":"Zhang","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e079115","DOI":"10.1136\/bmjopen-2023-079115","article-title":"Willingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/cid\/ciaa014","article-title":"Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study","volume":"72","author":"Martins","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00105-024-05367-y","article-title":"Clinical presentation and treatment of herpes zoster and postherpetic neuralgia","volume":"75","author":"H\u00fcning","year":"2024","journal-title":"Dermatologie (Heidelberg, Germany)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40121-023-00899-7","article-title":"Global prevalence of varicella-associated complications: a systematic review and meta-analysis","volume":"13","author":"Shah","year":"2024","journal-title":"Infect Dis Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.2169\/internalmedicine.3047-23","article-title":"The diversity of neurological complications associated with herpes zoster: a retrospective case series of 26 patients","volume":"63","author":"Nemoto","year":"2024","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3949\/ccjm.91a.24019","article-title":"Preventing herpes zoster in immunocompromised patients: current concepts","volume":"91","author":"Calabrese","year":"2024","journal-title":"Cleve Clin J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1093\/cid\/ciz1090","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review","volume":"71","author":"McKay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet (London, England)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"994619","DOI":"10.3389\/fpubh.2022.994619","article-title":"Long-term trends in the burden of inflammatory bowel disease in China over three decades: a joinpoint regression and age-period-cohort analysis based on GBD 2019","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1186\/s12889-021-11401-8","article-title":"Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and joinpoint analysis","volume":"21","author":"Guo","year":"2021","journal-title":"BMC Public Health"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3760\/cma.j.issn.0254-6450.2016.08.013","article-title":"Application of R-based multiple seasonal ARIMA model, in predicting the incidence of hand, foot and mouth disease in Shaanxi province","volume":"37","author":"Liu","year":"2016","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3760\/cma.j.cn112150-20211221-01174","article-title":"An investigation on serum antibody level of varicella-zoster virus in healthy population in Beijing","volume":"56","author":"Suo","year":"2022","journal-title":"Zhonghua yu fang yi xue za zhi [Chinese J Prev Med]"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/14760584.2021.1963236","article-title":"Impact of a two-dose varicella immunization program on the incidence of varicella: a multi-year observational study in Shanghai, China","volume":"20","author":"Li","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(19)32136-1","article-title":"10 years of health-care reform in China: progress and gaps in universal health coverage","volume":"394","author":"Yip","year":"2019","journal-title":"Lancet (London, England)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0140-6736(11)61880-1","article-title":"Early appraisal of China's huge and complex health-care reforms","volume":"379","author":"Yip","year":"2012","journal-title":"Lancet (London, England)."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12939-022-01811-4","article-title":"Strengthening and expanding health inequality monitoring for the advancement of health equity: a review of WHO resources and contributions","volume":"22","author":"Hosseinpoor","year":"2023","journal-title":"Int J Equity Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12992-019-0514-6","article-title":"Editorial: the political determinants of health inequities and universal health coverage","volume":"15","author":"Kittelsen","year":"2019","journal-title":"Glob Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12962-023-00505-0","article-title":"Population ageing and sustainability of healthcare financing in China","volume":"21","author":"Wu","year":"2023","journal-title":"Cost Eff Resour Alloc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/v15081663","article-title":"The spectrum of neurological manifestations of varicella-zoster virus reactivation","volume":"15","author":"Kennedy","year":"2023","journal-title":"Viruses"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0152660","DOI":"10.1371\/journal.pone.0152660","article-title":"Disease burden due to herpes zoster among population aged \u226550 years old in China: a community based retrospective survey","volume":"11","author":"Li","year":"2016","journal-title":"PloS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annepidem.2005.12.002","article-title":"Gender as an independent risk factor for herpes zoster: a population-based prospective study","volume":"16","author":"Opstelten","year":"2006","journal-title":"Ann Epidemiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2188\/jea.JE20140210","article-title":"Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study","volume":"25","author":"Takao","year":"2015","journal-title":"J Epidemiol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1535977\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:47:44Z","timestamp":1741589264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1535977\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2025.1535977"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1535977","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"article-number":"1535977"}}